AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
May 17 2021
News
Biden administration to send 20 million U.S.-authorized vaccine doses abroad
President Biden will send an additional 20 million doses of coronavirus vaccines to other countries by the end of June, including shots authorized by the FDA for use in the U.S., White House press secretary Jen Psaki said Monday.
Why it matters: It will be the first time the U.S. has sent Pfizer, Moderna, and Johnson & Johnson vaccine doses abroad. The administration previously
AxiosDec 01 2020
News
How drug companies will profit from making Covid-19 vaccines
The world has two, and possibly three, Covid-19 vaccines ready to be distributed before the end of the year. In several months, a significant part of the global population will have received at least the first dose of the vaccine, which means the makers—so far Pfizer, Moderna, and AstraZeneca—will have collectively sold billions of doses.
While these pharmaceutical companies are filling
QuartzJun 24 2022
News
Sanofi, GSK variant-specific COVID shot found effective against Omicron
PARIS/LONDON, June 24 (Reuters) - Late-stage data on an experimental COVID-19 vaccine from Sanofi (SASY.PA) and GSK (GSK.L) has showed the shot confers protection against the Omicron variant of the virus, the companies said on Friday.
The so-called bivalent vaccine targets the Beta variant - first identified in South Africa - as well as the original Wuhan strain of the virus.
In
ReutersNov 24 2020
Analysis
When might a COVID-19 vaccine be authorized? FDA Commissioner Stephen Hahn answers common questions
A COVID-19 vaccine could come within weeks – at least a limited supply to front-line medical workers. Drug companies Pfizer, Moderna and AstraZeneca have the leading vaccine candidates. Several others remain in development.
The Food and Drug Administration is responsible for authorizing and approving all vaccines in the USA. Widespread vaccine use once one is given the green light could
USA TODAYDec 14 2020
Opinion
After Health Care Workers, Focus on Getting Vaccines Out Quickly
California and other states are discussing how to disseminate COVID-19 vaccinations and who will be offered them first. The state’s plan says when California gets its first batch of vaccines that health care workers who interact with patients at acute care, psychiatric and correctional facility hospitals, workers at skilled nursing facilities, paramedics, and workers at dialysis centers will
Marc JoffeDec 10 2020
Background
What Are the Side Effects of COVID-19 Vaccines?
News around coronavirus vaccine progress has been positive in recent weeks. Two vaccine candidates — one from Pfizer/BioNTech and another from Moderna/National Institutes of Health (NIH) — are being reviewed by the U.S. Food and Drug Administration (FDA) for emergency authorization. If all goes smoothly, priority populations could start being inoculated before the end of the year.
But
AARPDec 07 2020
News
President Trump to hold White House COVID-19 summit as pressure mounts for FDA vaccine approval
President Donald Trump is set to kick off a summit at the White House Tuesday to highlight the rapid development of a COVID-19 vaccine he is eager to take credit for despite criticism for his handling of the coronavirus pandemic.
The summit, designed to provide an update on the status of the administration's ambitious plan to vaccinate all Americans against the coronavirus, comes two
USA TODAYNov 23 2020
News
Oxford's Coronavirus Vaccine Is 70% Effective, Early Data Shows. It's The Third Vaccine To Clear A Crucial Hurdle.
A COVID-19 vaccine developed by the University of Oxford and AstraZeneca has shown "positive high-level results" in early data from clinical trials, researchers announced Monday. It is the third vaccine to clear that crucial hurdle, alongside ones made by Pfizer and Moderna.
The vaccine has been 70% effective on average so far, researchers said. The early data came with a potentially
BuzzFeed NewsNov 18 2020
Opinion
Rebuilding public trust will instill COVID-19 vaccine confidence
Moderna’s 94.5 percent vaccine efficacy rate brings renewed hope that a preventative therapy to reduce the spread of COVID-19 may be close at hand. This news is especially welcome as cases continue to spike across the country. But unless the American people trust it (or any of the other vaccines currently under development for that matter), nothing will change.
Only half of the American
The HillDec 31 2020
News
West Virginia clinic gave 44 people an antibody treatment instead of the coronavirus vaccine
Forty-four people received an antibody treatment instead of Moderna’s coronavirus vaccine in an error Wednesday at a vaccination clinic in Boone County, W.Va.
The West Virginia National Guard, which announced the error Thursday, said medical experts advising the state’s covid-19 response “do not believe there is any risk of harm” to the people. The Guard’s statement indicated 42
Washington Post